Literature DB >> 6374949

The excretion of antibiotics by the biliary tract.

H Nagar, S A Berger.   

Abstract

Although the clinical significance of a high antibiotic level of the biliary tract has not been proved, few antibiotics are both well excreted and active against the common pathogens of bile. The biliary excretion of these agents is a complex phenomenon which may be altered by a number of host factors. The results of studies on the levels of antimicrobial agents vary with respect to the timing of antibiotic measurement, type of bile sampled, presence or absence of biliary tract obstruction and assessment of data.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6374949

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  5 in total

1.  Penetration of cefazolin, ceftriaxone, cefoperazone, and ceftazidime into human gallbladder tissue and bile.

Authors:  S A Berger; Y Levy; A Halevy; A Gorea; R Orda
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

2.  Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice.

Authors:  J I Blenkharn; N Habib; D Mok; L John; G A McPherson; R N Gibson; L H Blumgart; I S Benjamin
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

3.  Experimental studies of biliary excretion of piperacillin.

Authors:  P Calhoun; K B Brown; R Strunk; D A Krusch; W M Scheld; J B Hanks
Journal:  Ann Surg       Date:  1987-04       Impact factor: 12.969

4.  Aztreonam concentration in abdominal tissues and bile.

Authors:  R E Condon; L T Friedhoff; C E Edmiston; B Levinson
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

5.  Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media- a single center retrospective study.

Authors:  Hella Wobser; Agnetha Gunesch; Frank Klebl
Journal:  BMC Gastroenterol       Date:  2017-01-13       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.